Infectious Diseases
Ibogaine reduces organ colonization in systemic and GI C. albicans infections
Published in Anti-Infectives Week, October 31st, 2005
According to recent research from Bulgaria, "In the present study the effect of the indole alkaloid ibogaine on the in vitro lipolytic activity and adherence to epithelial cells of Candida albicans was investigated.
"The substance was administered intraperitoneally at a dose of 5 mg kg-1 day(-1) in mice with disseminated and gastrointestinal C. albicans infections."
Ibogaine significantly decreased the rate of mortality and the number of C. albicans c.f.u. recovered from the kidney, liver and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
Source: Anti-Infectives Week (2005-10-31)
More Articles from Anti-Infectives Week
- Antibacterial Agents
Ochrobactrum anthropi D-aminopeptidase specificity inversion reported - Fungal Bloodstream Infection
Delaying empiric treatment for positive blood culture heightens mortality risk - Infection Control
Titanium oxide photocatalyst enhances ultrasonic irradiation-based disinfection - Salmonellosis Therapy
Beta-lactam resistance investigated in Enterobacteriaceae - Anthrax
Fast-tracked anthrax drug, Anthim, advances into human clinical trials - Antibacterial Agents
Erythromycin increases bactericidal activity of surface liquid in human airway epithelial cells - More from this issue of Anti-Infectives Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
